In agreement with our observations, a meta-analysis using 23 independent studies recently concluded that a high BECN1 expression was a favorable predictive factor for overall survival (OS) in BC, gastric cancers and lymphomas, whereas high levels of LC3B were inversely correlated with OS in BC [23]. Here, MAP1LC3B is linked to breast cancer.